Keyphrases
Urinary Cotinine
95%
COVID-19
68%
COVID-19 Patients
63%
Cotinine
62%
Jakarta
47%
Cigarette Smoking
44%
Cigarette Smoke Exposure
42%
Indonesian children
40%
Inhalation
40%
Hospitalization
37%
Smokers
37%
Smoking Habits
35%
Elementary School children
35%
Brief Psychotic Disorder
31%
Psychological Coping
31%
Fear of COVID-19
31%
COVID-19 Factors
31%
Secondary Spontaneous Pneumothorax
31%
Shisha Smoking
31%
Shisha
31%
School Absence
31%
Nitrogen Dioxide NO2
31%
Inflammatory Markers
31%
Community Members
31%
Coping Strategies
31%
Outcome Prediction
31%
Silicosis
31%
NO2 Exposure
31%
Oxalic Acid
31%
Psychological Distress
31%
Psychological Fear
31%
Inhibition Effect
31%
Exhaled Carbon Monoxide
31%
Glutathione
31%
Superoxide Dismutase
31%
In Vitro Inhibition
31%
Klebsiella Pneumoniae (K. pneumoniae)
31%
Indonesian
31%
Mental Illness
31%
Dependence Levels
31%
Propolis
31%
Environmental Tobacco Smoke
31%
Indoor Particulate Matter
31%
Pulmonary Alveolar Proteinosis
31%
CO2 Concentration
31%
Particulate Matter 2.5 (PM2.5)
31%
Respiratory Complaints
31%
Junior High School Students
31%
Length of Hospital Stay
31%
High-flow Nasal Oxygen
31%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Cigarette Smoke
79%
Coronavirinae
63%
Lung Alveolus Proteinosis
31%
Ethylene Oxide
31%
Brief Psychotic Disorder
31%
Cotinine
31%
Nitrogen Dioxide
31%
Epileptic Absence
31%
Glutathione
31%
Klebsiella pneumoniae
31%
Propolis
31%
Superoxide Dismutase
31%
Insect Repellent
31%
Surfactant Protein D
31%
Placebo
31%
Group Trial
31%
Lung Tuberculosis
31%
Acetylcysteine
31%
Upper Respiratory Tract Infection
26%
Coughing
23%
Dimer
21%
Fibrinogen
21%
Symptom
21%
Antiinfective Agent
18%
Cross-Sectional Study
16%
Dietary Supplement
15%
Comorbidity
15%
Infection
15%
Prospective Cohort Study
15%
Gram Negative Bacterium
13%
Respiratory Tract Infection
12%
Carbon Monoxide
12%
Blood Clotting Disorder
10%
Hospital Mortality
10%
Pandemic
10%
Chronic Obstructive Lung Disease
10%
Lung Cancer
10%
Asthma
10%
Withdrawal Syndrome
10%
Antibacterial Activity
9%
Filgrastim
7%
Lung Disease
7%
Dyspnea
7%
Tuberculostatic Agent
7%
Periodic Acid
7%
Prevalence
7%
Tuberculosis
7%
Tobacco Dependence
7%
Randomized Controlled Trial
7%